Welcome to the Hope Bio Blog

Written by Jan Shultis Billions of stem cells manufactured through proprietary technology by Houston-area biotechnology company Hope Biosciences are soon to be pressed into the fight against Alzheimer’s Disease (AD).   The U.S. Food and Drug Administration (FDA) has authorized an open label Phase Ib/IIa clinical trial to evaluate whether Hope Biosciences autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) reduce inflammation in the brain, improve brain activity, an

Hope Biosciences, a clinical-stage biotechnology company today shares positive top-line results of a Phase II clinical trial.

How and why to enroll in FDA-authorized, DoD-backed research using Hope Bio's cells in TBI